Video Latest - ecancer

High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology

Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands

25 Mar 2014

Molecular pathways associated with immune modulation and thalidomide analogues

Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene

25 Mar 2014

Multiple Myeloma Debate 2014: Recent advances in multiple myeloma

Dr Pieter Sonneveld, Prof Michele Cavo, Dr Jesus San Miguel and Dr Meletios Dimopoulos

2 Feb 2014

Critical insights on leukaemia and lymphoma from ASH 2013

Prof Robin Foa, Dr Simon Rule, Dr Clemens Wendtner

2 Feb 2014

Trial results at ASH 2013

Prof Ian Flinn - Sarah Cannon Cancer Center, Nashville, Tennessee, USA

1 Jan 2014

Rituximab maintenance therapy and CLL treatment considerations going forward

Prof Ulrich Jäger - Medical University of Vienna, Austria

1 Jan 2014

Oncotype DX: changing breast cancer treatment

Dr Norman Wolmark - National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, USA

19 Dec 2013

Meeting the needs of the elderly, unfit CLL patient

Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK

19 Dec 2013

Improving outcomes in chronic lymphocytic leukaemia

Prof John Gribben - Queen Mary University of London, UK and Prof Barbara Eichhorst - University of Cologne, Germany

19 Dec 2013

Where next for chronic lymphocytic leukaemia in the elderly?

Prof Clemens Wendter, Prof Florence Cymbalista, Prof Anders Österborg

19 Dec 2013

A new trial alters therapy landscape in multiple myeloma

Prof Philippe Moreau - University Hospital Hôtel-Dieu, Nantes, France and Dr Maria-Victoria Mateos - University Hospital of Salamanca, Spain

19 Dec 2013

Where to next for the elderly with acute myeloid leukaemia?

Dr Uwe Platzbecker - University Hospital Dresden, Germany and Prof Gert Ossenkoppele - VU University Medical Center, Amsterdam, Netherlands

19 Dec 2013

Video